⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL171443 | 0.79 | — | — | |
| SCHEMBL28108721 | 0.79 | — | — | |
| SCHEMBL29182650 | 0.78 | — | — | |
| SCHEMBL20873772 | 0.78 | — | — | |
| SCHEMBL10771287 | 0.78 | — | — | |
| SCHEMBL1691828 | 0.76 | — | — | |
| SCHEMBL28858413 | 0.76 | — | — | |
| SCHEMBL8760701 | 0.75 | — | — | |
| SCHEMBL28141228 | 0.75 | — | — | |
| SCHEMBL28146912 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494960-B1 | STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME | HELSINN HEALTHCARE SA (CH) | 2020-11-25 | — | — | EP | disclosed |
| EP-3377048-B1 | ABUSE RESISTANT TRANSDERMAL DELIVERY DEVICES AND COMPOSITIONS COMPRISING AN OPIOID AGONIST AND A NON-TRANSDERMALLY DELIVERED N-OXIDE DERIVATIVE OF AN OPIOID ANTAGONIST FOR THE TREATMENT OF PAIN | EURO CELTIQUE SA (LU) | 2020-04-22 | — | — | EP | disclosed |
| EP-3494960-A1 | STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME | Helsinn Healthcare SA (CH) | 2019-06-12 | — | — | EP | disclosed |
| US-20180344726-A1 | ABUSE RESISTANT TRANSDERMAL DELIVERY DEVICES AND COMPOSITIONS COMPRISING AN OPIOID AGONIST AND A NON-TRANSDERMALLY DELIVERED N-OXIDE DERIVATIVE OF AN OPIOID ANTAGONIST FOR THE TREATMENT OF PAIN | EURO-CELTIQUE S.A. (LU) | 2018-12-06 | — | — | US | disclosed |
| EP-3377048-A1 | ABUSE RESISTANT TRANSDERMAL DELIVERY DEVICES AND COMPOSITIONS COMPRISING AN OPIOID AGONIST AND A NON-TRANSDERMALLY DELIVERED N-OXIDE DERIVATIVE OF AN OPIOID ANTAGONIST FOR THE TREATMENT OF PAIN | Euro-Celtique S.A. (LU) | 2018-09-26 | — | — | EP | disclosed |
| US-9382191-B2 | Stabilized compositions of volatile alkylating agents and methods of using thereof | ACTELION PHARMACEUTICALS, LTD. (CH) | 2016-07-05 | — | — | US | disclosed |
| US-20140194526-A1 | STABILIZED COMPOSITIONS OF VOLATILE ALKYLATING AGENTS AND METHODS OF USING THEREOF | ACTELION PHARMACEUTICALS LTD. (CH) | 2014-07-10 | — | — | US | disclosed |
| US-20140187810-A1 | STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME | ACTELION PHARMACEUTICALS, LTD. (CH) | 2014-07-03 | — | — | US | disclosed |
| US-20140155491-A1 | Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof | ACTELION PHARMACEUTICALS, LTD. (CH) | 2014-06-05 | — | — | US | disclosed |
| US-20140142193-A1 | Stabilized Compositions Of Alkylating Agents And Methods Of Using Same | ACTELION PHARMACEUTICALS, LTD. (CH) | 2014-05-22 | — | — | US | disclosed |
| WO-2004017941-A2 | TRANSDERMAL DOSAGE FORM COMPRISING AN ACTIVE AGENT AND A SALT AND FREE-BASEFORM OF AN ANTAGONIST | EURO-CELTIQUE, S.A. (LU) | 2004-03-04 | — | — | WO | disclosed |
| US-20040033253-A1 | Acyl opioid antagonists | PURDUE PHARMA L.P. | 2004-02-19 | — | — | US | disclosed |
| WO-2003070191-A2 | TAMPER-RESISTANT TRANSDERMAL OPIOID DELIVERY DEVICES | EURO-CELTIQUE, S.A. (LU) | 2003-08-28 | — | — | WO | disclosed |
| US-20030125659-A1 | Dosage of transdermal delivery systems | EURO-CELTIQUE S.A. (LU) | 2003-07-03 | — | — | US | disclosed |
| US-6569449-B1 | For treatment of eating disorders, narcotic dependence and alcoholism. | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2003-05-27 | — | — | US | disclosed |
| US-5149538-A | Misuse-resistive transdermal opioid dosage form | WARNER-LAMBERT COMPANY (US) | 1992-09-22 | — | — | US | disclosed |
| EP-0290482-A4 | TRANSDERMAL ABSORPTION DOSAGE UNIT FOR NARCOTIC ANALGESICS AND ANTAGONISTS AND PROCESS FOR ADMINISTRATION | — | 1990-11-28 | — | — | EP | disclosed |
| US-4806341-A | BACKING LAYER, POLYMER MATRIX DISC WITH DRUG MICRODISPERSED THEREIN | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 1989-02-21 | — | — | US | disclosed |
| EP-0290482-A1 | TRANSDERMAL ABSORPTION DOSAGE UNIT FOR NARCOTIC ANALGESICS AND ANTAGONISTS AND PROCESS FOR ADMINISTRATION. | UNIV NEW JERSEY (US) | 1988-11-17 | — | — | EP | disclosed |
| WO-1988001497-A1 | TRANSDERMAL ABSORPTION DOSAGE UNIT FOR NARCOTIC ANALGESICS AND ANTAGONISTS AND PROCESS FOR ADMINISTRATION | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 1988-03-10 | — | — | WO | disclosed |